{"id":30216,"date":"2022-03-04T09:08:49","date_gmt":"2022-03-04T15:08:49","guid":{"rendered":"https:\/\/brakkeconsulting.com\/?p=30216"},"modified":"2022-03-11T08:51:19","modified_gmt":"2022-03-11T14:51:19","slug":"30216-2","status":"publish","type":"post","link":"https:\/\/brakkeconsulting.com\/zh\/30216-2\/","title":{"rendered":"\u5e03\u62c9\u514b\u89c2\u70b9 2022 \u5e74 3 \u6708 4 \u65e5"},"content":{"rendered":"<p>\u5bf9\u6211\u6765\u8bf4\uff0c\u7855\u817e\u7684 Draxxin\u00ae \u5c31\u662f\u6700\u597d\u7684\u4f8b\u5b50\uff0c\u5b83\u89e3\u91ca\u4e86\u755c\u7267\u751f\u4ea7\u8005\u613f\u610f\u4e3a\u521b\u65b0\u4e70\u5355\u3002Draxxin \u4e2d\u7684\u6297\u751f\u7d20 Tulathromycin \u975e\u5e38\u6709\u6548\uff0c\u755c\u7267\u751f\u4ea7\u8005\u613f\u610f\u82b1\u9ad8\u4ef7\u8d2d\u4e70\u5b83\u6765\u6cbb\u7597\u4ed6\u4eec\u7684\u725b\u548c\u732a\u2014\u2014\u5b83\u6709\u6548\u3002<\/p>\n<p>\u9ed8\u514b\u548c Elanco \u73b0\u5728\u52a0\u5165\u4e86 Bimeda\u3001Ceva \u548c Virbac \u7684\u884c\u5217\uff0c\u83b7\u5f97\u4e86 Tulathromycin \u4eff\u5236\u836f\u7684\u6279\u51c6\uff0c\u4f7f FDA \u6279\u51c6\u7684\u4eff\u5236\u836f\u603b\u6570\u8fbe\u5230\u4e94\u79cd\uff0c\u8fd9\u8bc1\u660e\u6a21\u4eff\u4e5f\u662f\u52a8\u7269\u4fdd\u5065\u9886\u57df\u6700\u5927\u7684\u5949\u627f\u5f62\u5f0f\u3002\u5728\u4e0a\u4e2a\u6708\u7684 Zoetis \u8d22\u62a5\u7535\u8bdd\u4f1a\u8bae\u4e0a\uff0c\u4ed6\u4eec\u5ba3\u5e03\u4eff\u5236\u836f\u7ade\u4e89\u4f7f Draxxin \u7684\u6536\u5165\u5728 2021 \u5e74\u4e0e 2020 \u5e74\u76f8\u6bd4\u51cf\u5c11\u4e86 15%\uff0c\u4ed6\u4eec\u9884\u8ba1 2022 \u5e74\u4e0e 2021 \u5e74\u76f8\u6bd4\u5c06\u518d\u6b21\u4e0b\u964d 20%\u2014\u2014\u9500\u552e\u9ad8\u5cf0\u671f\u5df2\u6210\u4e3a\u8fc7\u53bb\u3002<\/p>\n<p>\u4e0d\u5e78\u7684\u662f\uff0c\u8fd9\u4e9b\u6cf0\u62c9\u9709\u7d20\u7ade\u4e89\u5bf9\u624b\u4eca\u5e74\u5c06\u5728\u7272\u755c\u5e02\u573a\u4e0a\u5c55\u5f00\u7ade\u4e89\uff0c\u9884\u8ba1\u4eca\u5e74\u7684\u7272\u755c\u5e02\u573a\u4e0d\u4f1a\u6bd4 2021 \u5e74\u589e\u957f\u592a\u591a\u3002\u7f8e\u56fd\u519c\u4e1a\u90e8\u9884\u8ba1 2022 \u5e74\u725b\u8089\u4ea7\u91cf\u5c06\u5c0f\u5e45\u4e0a\u5347\uff0c\u800c 2022 \u5e74\u732a\u8089\u4ea7\u91cf\u53ef\u80fd\u7565\u4f4e\u4e8e 2021 \u5e74\u3002\u7531\u4e8e\u9972\u6599\u548c\u6295\u5165\u6210\u672c\u4e0a\u5347\uff0c\u751f\u4ea7\u5546\u7684\u5229\u6da6\u5168\u5e74\u90fd\u5c06\u627f\u53d7\u538b\u529b\u3002\uff08\u4f46\u6cf0\u62c9\u9709\u7d20\u7684\u6210\u672c\u4e0d\u4f1a\u66f4\u9ad8\u3002\uff09<\/p>\n<p>Draxxin \u662f\u4e00\u6b3e\u51fa\u8272\u7684\u4ea7\u54c1\uff0c\u4e00\u4e2a\u51fa\u8272\u7684\u54c1\u724c\u3002\u9274\u4e8e Zoetis \u548c\u5176\u4ed6\u5927\u578b\u52a8\u7269\u4fdd\u5065\u516c\u53f8\u7684\u6210\u529f\u521b\u65b0\uff0c\u6211\u4eec\u5e0c\u671b\u80fd\u53d1\u73b0\u4e00\u79cd\u65b0\u7684\u201cDraxxin\u201d\u3002\u8bf7\u8bb0\u4f4f\uff0c\u755c\u7267\u751f\u4ea7\u8005\u5c06\u4e3a\u521b\u65b0\u4e70\u5355\u3002<\/p>\n<p><em>\u9c8d\u52c3\u00b7\u743c\u65af<\/em><\/p>","protected":false},"excerpt":{"rendered":"<p>\u7855\u817e\u7684Draxxin\u00ae\u4e00\u76f4\u662f\u6211\u7528\u6765\u89e3\u91ca\u755c\u7267\u751f\u4ea7\u8005\u613f\u610f\u4e3a\u521b\u65b0\u4e70\u5355\u7684\u6700\u4f73\u4f8b\u8bc1\u3002Draxxin\u4e2d\u7684\u6297\u751f\u7d20\u571f\u62c9\u9709\u7d20\uff08Tulathromycin\uff09\u7597\u6548\u663e\u8457\uff0c\u755c\u7267\u751f\u4ea7\u8005\u613f\u610f\u4e3a\u6b64\u652f\u4ed8\u9ad8\u4ef7\u6765\u6cbb\u7597\u4ed6\u4eec\u7684\u725b\u548c\u732a\u2014\u2014\u56e0\u4e3a\u5b83\u6709\u6548\u3002\u9ed8\u514b\u548c\u793c\u6765\u73b0\u5728\u52a0\u5165\u4e86\u767e\u7f8e\u8fbe\uff08Bimeda\uff09\u3001\u8bd7\u534e\uff08Ceva\uff09\u548c\u7ef4\u514b\uff08Virbac\uff09\u7684\u884c\u5217\uff0c\u83b7\u5f97\u4e86\u571f\u62c9\u9709\u7d20\u7684\u4eff\u5236\u836f\u6279\u51c6\uff0c\u4f7fFDA\u6279\u51c6\u7684\u4eff\u5236\u836f\u603b\u6570\u8fbe\u5230\u4e94\u79cd\uff0c\u8fd9\u8bc1\u660e\u4e86\u6a21\u4eff\u4e5f\u662f\u52a8\u7269\u4fdd\u5065\u9886\u57df\u6700\u5927\u7684\u5671\u5934\u3002\u5728\u4e0a\u4e2a\u6708\u7855\u817e\u7684\u8d22\u62a5\u7535\u8bdd\u4f1a\u8bae\u4e0a\uff0c\u4ed6\u4eec\u5ba3\u5e03\u4eff\u5236\u836f\u7684\u7ade\u4e89\u5bfc\u81f4Draxxin 2021\u5e74\u7684\u6536\u5165\u4e0e2020\u5e74\u76f8\u6bd4\u51cf\u5c11\u4e8615%\uff0c\u4ed6\u4eec\u9884\u8ba12022\u5e74\u7684\u6536\u5165\u5c06\u4e0e2021\u5e74\u76f8\u6bd4\u518d\u6b21\u4e0b\u964d20%\u2014\u2014\u9500\u552e\u9ad8\u5cf0\u671f\u5df2\u7ecf\u8fc7\u53bb\u3002\u4e0d\u5e78\u7684\u662f\uff0c\u8fd9\u4e9b\u6cf0\u62c9\u9709\u7d20\u7684\u7ade\u4e89\u5bf9\u624b\u4eca\u5e74\u5c06\u5728\u755c\u7267\u4e1a\u5e02\u573a\u4e2d\u82e6\u82e6\u6323\u624e\uff0c\u9884\u8ba1\u4eca\u5e74\u755c\u7267\u4e1a\u5e02\u573a\u4e0d\u4f1a\u6bd42021\u5e74\u589e\u957f\u592a\u591a\u3002\u7f8e\u56fd\u519c\u4e1a\u90e8\u9884\u8ba1\uff0c2022\u5e74\u725b\u8089\u4ea7\u91cf\u5c06\u5c0f\u5e45\u589e\u957f\uff0c\u800c\u732a\u8089\u4ea7\u91cf\u53ef\u80fd\u7565\u4f4e\u4e8e2021\u5e74\u3002\u7531\u4e8e\u9972\u6599\u548c\u6295\u5165\u6210\u672c\u7684\u4e0a\u6da8\uff0c\u751f\u4ea7\u5546\u7684\u5229\u6da6\u5168\u5e74\u90fd\u5c06\u9762\u4e34\u538b\u529b\u3002\uff08\u4f46\u6cf0\u62c9\u9709\u7d20\u7684\u6210\u672c\u4e0d\u4f1a\u4e0a\u6da8\u3002\uff09Draxxin\u662f\u4e00\u6b3e\u4f18\u79c0\u7684\u4ea7\u54c1\uff0c\u4e00\u4e2a\u4f18\u79c0\u7684\u54c1\u724c\u3002\u9274\u4e8e\u7855\u817e\u548c\u5176\u4ed6\u5927\u578b\u52a8\u7269\u4fdd\u5065\u516c\u53f8\u7684\u6210\u529f\u521b\u65b0\uff0c\u6211\u4eec\u5e0c\u671b\u80fd\u591f\u2026\u2026<\/p>\n<div class=\"view-full-post\"><a href=\"https:\/\/brakkeconsulting.com\/zh\/30216-2\/\" class=\"view-full-post-btn\">\u67e5\u770b\u5b8c\u6574\u6587\u7ae0<\/a><\/div>\n<p>;<\/p>","protected":false},"author":19,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":"","_links_to":"","_links_to_target":""},"categories":[43],"tags":[],"class_list":["post-30216","post","type-post","status-publish","format-standard","hentry","category-viewpoints"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>News from Brakke Consulting<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/brakkeconsulting.com\/zh\/30216-2\/\" \/>\n<meta property=\"og:locale\" content=\"zh_CN\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"News from Brakke Consulting\" \/>\n<meta property=\"og:description\" content=\"Zoetis\u2019s Draxxin\u00ae has been the best example for me to use to explain that livestock producers will pay for innovation.\u00a0 Tulathromycin, the antibiotic in Draxxin, is highly effective and livestock producers are willing to pay the high price for it to treat their cattle and swine \u2013 it works. Merck and Elanco now join Bimeda, Ceva and Virbac in having a generic tulathromycin approved, bringing the total FDA approved generic products to five, proof that imitation is the greatest form of flattery in animal health as well. In Zoetis\u2019s earnings call last month, they announced that generic competition reduced Draxxin revenue 15% in 2021 compared to 2020 and they expect another decline in 2022 of 20% compared to 2021 \u2013 peak sales are now in the past. Unfortunately, these tulathromycin competitors will be battling in a livestock market this year that is forecasted to not grow much from 2021.\u00a0 The USDA expects beef production to be up fractionally in 2022 and pork production for 2022 will likely be slightly lower that 2021.\u00a0 And producer profits will be under pressure all year due to higher feed and input costs.\u00a0 (But tulathromycin costs won\u2019t be higher.) Draxxin is a great product, a great brand.\u00a0 Given the successful innovation from Zoetis and the other major animal health companies, we hope there is aView Full Post;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/brakkeconsulting.com\/zh\/30216-2\/\" \/>\n<meta property=\"og:site_name\" content=\"Brakke Consulting Website\" \/>\n<meta property=\"article:published_time\" content=\"2022-03-04T15:08:49+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2022-03-11T14:51:19+00:00\" \/>\n<meta name=\"author\" content=\"Amanda McDavid\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u4f5c\u8005\" \/>\n\t<meta name=\"twitter:data1\" content=\"Amanda McDavid\" \/>\n\t<meta name=\"twitter:label2\" content=\"\u9884\u8ba1\u9605\u8bfb\u65f6\u95f4\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 \u5206\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/brakkeconsulting.com\\\/30216-2\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/brakkeconsulting.com\\\/30216-2\\\/\"},\"author\":{\"name\":\"Amanda McDavid\",\"@id\":\"https:\\\/\\\/brakkeconsulting.com\\\/#\\\/schema\\\/person\\\/cbd3330707aa1f20925a2f9d78722615\"},\"headline\":\"Brakke Viewpoint March 4, 2022\",\"datePublished\":\"2022-03-04T15:08:49+00:00\",\"dateModified\":\"2022-03-11T14:51:19+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/brakkeconsulting.com\\\/30216-2\\\/\"},\"wordCount\":227,\"articleSection\":[\"Viewpoints\"],\"inLanguage\":\"zh-Hans\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/brakkeconsulting.com\\\/30216-2\\\/\",\"url\":\"https:\\\/\\\/brakkeconsulting.com\\\/30216-2\\\/\",\"name\":\"News from Brakke Consulting\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/brakkeconsulting.com\\\/#website\"},\"datePublished\":\"2022-03-04T15:08:49+00:00\",\"dateModified\":\"2022-03-11T14:51:19+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/brakkeconsulting.com\\\/#\\\/schema\\\/person\\\/cbd3330707aa1f20925a2f9d78722615\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/brakkeconsulting.com\\\/30216-2\\\/#breadcrumb\"},\"inLanguage\":\"zh-Hans\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/brakkeconsulting.com\\\/30216-2\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/brakkeconsulting.com\\\/30216-2\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/brakkeconsulting.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Brakke Viewpoint March 4, 2022\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/brakkeconsulting.com\\\/#website\",\"url\":\"https:\\\/\\\/brakkeconsulting.com\\\/\",\"name\":\"Brakke Consulting Website\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/brakkeconsulting.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"zh-Hans\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/brakkeconsulting.com\\\/#\\\/schema\\\/person\\\/cbd3330707aa1f20925a2f9d78722615\",\"name\":\"Amanda McDavid\",\"url\":\"https:\\\/\\\/brakkeconsulting.com\\\/zh\\\/author\\\/amanda\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"\u6765\u81ea Brakke Consulting \u7684\u65b0\u95fb","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/brakkeconsulting.com\/zh\/30216-2\/","og_locale":"zh_CN","og_type":"article","og_title":"News from Brakke Consulting","og_description":"Zoetis\u2019s Draxxin\u00ae has been the best example for me to use to explain that livestock producers will pay for innovation.\u00a0 Tulathromycin, the antibiotic in Draxxin, is highly effective and livestock producers are willing to pay the high price for it to treat their cattle and swine \u2013 it works. Merck and Elanco now join Bimeda, Ceva and Virbac in having a generic tulathromycin approved, bringing the total FDA approved generic products to five, proof that imitation is the greatest form of flattery in animal health as well. In Zoetis\u2019s earnings call last month, they announced that generic competition reduced Draxxin revenue 15% in 2021 compared to 2020 and they expect another decline in 2022 of 20% compared to 2021 \u2013 peak sales are now in the past. Unfortunately, these tulathromycin competitors will be battling in a livestock market this year that is forecasted to not grow much from 2021.\u00a0 The USDA expects beef production to be up fractionally in 2022 and pork production for 2022 will likely be slightly lower that 2021.\u00a0 And producer profits will be under pressure all year due to higher feed and input costs.\u00a0 (But tulathromycin costs won\u2019t be higher.) Draxxin is a great product, a great brand.\u00a0 Given the successful innovation from Zoetis and the other major animal health companies, we hope there is aView Full Post;","og_url":"https:\/\/brakkeconsulting.com\/zh\/30216-2\/","og_site_name":"Brakke Consulting Website","article_published_time":"2022-03-04T15:08:49+00:00","article_modified_time":"2022-03-11T14:51:19+00:00","author":"Amanda McDavid","twitter_card":"summary_large_image","twitter_misc":{"\u4f5c\u8005":"Amanda McDavid","\u9884\u8ba1\u9605\u8bfb\u65f6\u95f4":"2 \u5206"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/brakkeconsulting.com\/30216-2\/#article","isPartOf":{"@id":"https:\/\/brakkeconsulting.com\/30216-2\/"},"author":{"name":"Amanda McDavid","@id":"https:\/\/brakkeconsulting.com\/#\/schema\/person\/cbd3330707aa1f20925a2f9d78722615"},"headline":"Brakke Viewpoint March 4, 2022","datePublished":"2022-03-04T15:08:49+00:00","dateModified":"2022-03-11T14:51:19+00:00","mainEntityOfPage":{"@id":"https:\/\/brakkeconsulting.com\/30216-2\/"},"wordCount":227,"articleSection":["Viewpoints"],"inLanguage":"zh-Hans"},{"@type":"WebPage","@id":"https:\/\/brakkeconsulting.com\/30216-2\/","url":"https:\/\/brakkeconsulting.com\/30216-2\/","name":"\u6765\u81ea Brakke Consulting \u7684\u65b0\u95fb","isPartOf":{"@id":"https:\/\/brakkeconsulting.com\/#website"},"datePublished":"2022-03-04T15:08:49+00:00","dateModified":"2022-03-11T14:51:19+00:00","author":{"@id":"https:\/\/brakkeconsulting.com\/#\/schema\/person\/cbd3330707aa1f20925a2f9d78722615"},"breadcrumb":{"@id":"https:\/\/brakkeconsulting.com\/30216-2\/#breadcrumb"},"inLanguage":"zh-Hans","potentialAction":[{"@type":"ReadAction","target":["https:\/\/brakkeconsulting.com\/30216-2\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/brakkeconsulting.com\/30216-2\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/brakkeconsulting.com\/"},{"@type":"ListItem","position":2,"name":"Brakke Viewpoint March 4, 2022"}]},{"@type":"WebSite","@id":"https:\/\/brakkeconsulting.com\/#website","url":"https:\/\/brakkeconsulting.com\/","name":"Brakke\u54a8\u8be2\u7f51\u7ad9","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/brakkeconsulting.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"zh-Hans"},{"@type":"Person","@id":"https:\/\/brakkeconsulting.com\/#\/schema\/person\/cbd3330707aa1f20925a2f9d78722615","name":"\u963f\u66fc\u8fbe\u00b7\u9ea6\u514b\u6234\u7ef4","url":"https:\/\/brakkeconsulting.com\/zh\/author\/amanda\/"}]}},"_links":{"self":[{"href":"https:\/\/brakkeconsulting.com\/zh\/wp-json\/wp\/v2\/posts\/30216","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/brakkeconsulting.com\/zh\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/brakkeconsulting.com\/zh\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/brakkeconsulting.com\/zh\/wp-json\/wp\/v2\/users\/19"}],"replies":[{"embeddable":true,"href":"https:\/\/brakkeconsulting.com\/zh\/wp-json\/wp\/v2\/comments?post=30216"}],"version-history":[{"count":6,"href":"https:\/\/brakkeconsulting.com\/zh\/wp-json\/wp\/v2\/posts\/30216\/revisions"}],"predecessor-version":[{"id":30255,"href":"https:\/\/brakkeconsulting.com\/zh\/wp-json\/wp\/v2\/posts\/30216\/revisions\/30255"}],"wp:attachment":[{"href":"https:\/\/brakkeconsulting.com\/zh\/wp-json\/wp\/v2\/media?parent=30216"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/brakkeconsulting.com\/zh\/wp-json\/wp\/v2\/categories?post=30216"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/brakkeconsulting.com\/zh\/wp-json\/wp\/v2\/tags?post=30216"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}